Abstract
Evidence obtained from schizophrenia post-mortem brain studies have pointed to deficiencies in inhibitory systems, in particular of the fast-spiking parvalbumin (PV)-positive inhibitory interneurons, as responsible for several aspects of schizophrenia pathophysiology. This hypothesis has been confirmed in pharmacological as well as genetic models of the disease, but when and how this dysfunction occurs is still unknown. Exposure to NMDA receptor antagonists is one of the most used pharmacological models for the study of schizophrenia, due to its capacity to produce a psychotic syndrome in humans and to produce an outbreak in schizophrenia patients. Using this model, we and others have shown that dysfunction of the PV-inhibitory system is most probably responsible for the neural network alterations, leading to the schizophrenia-like behavior in primates and rodents. Development of PV-inhibitory neurons occurs postnatally in mammals and follows a predetermined program that occurs also in cultures of cortical neurons. In this chapter we describe in detail the methodology we have used over the last decade to culture these neurons and that led to the discovery of how blockade of NMDA receptors results in the dysfunction of PV interneurons.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ayhan, Y., Sawa, A., Ross, C.A., and Pletnikov, M.V. (2009). Animal models of gene–environment interactions in schizophrenia. Behav Brain Res 204, 274–281
Javitt, D.C. (2007). Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine–glutamate interactions. Int Rev Neurobiol 78, 69–108
Lewis, D.A., Hashimoto, T., and Volk, D.W. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6, 312–324
Mouri, A., Noda, Y., Enomoto, T., and Nabeshima, T. (2007). Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int 51, 173–184
Beasley, C.L., and Reynolds, G.P. (1997). Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24, 349–355
Benes, F.M., and Berretta, S. (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1–27
Hashimoto, T., Volk, D.W., Eggan, S.M., Mirnics, K., Pierri, J.N., Sun, Z., Sampson, A.R., and Lewis, D.A. (2003). Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23, 6315–6326
Ammassari-Teule, M., Sgobio, C., Biamonte, F., Marrone, C., Mercuri, N.B., and Keller, F. (2009). Reelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors. Psychopharmacology (Berl) 204, 511–521
Do, K.Q., Cabungcal, J.H., Frank, A., Steullet, P., and Cuenod, M. (2009). Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19, 220–230
Fisahn, A., Neddens, J., Yan, L., and Buonanno, A. (2009). Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex 19, 612–618
Hikida, T., Jaaro-Peled, H., Seshadri, S., Oishi, K., Hookway, C., Kong, S., Wu, D., Xue, R., Andrade, M., Tankou, S., Mori, S., Gallagher, M., Ishizuka, K., Pletnikov, M., Kida, S., and Sawa, A. (2007). Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 104, 14501–14506
Cardin, J.A., Carlen, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., Tsai, L.H., and Moore, C.I. (2009). Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459, 663–667
Doischer, D., Hosp, J.A., Yanagawa, Y., Obata, K., Jonas, P., Vida, I., and Bartos, M. (2008). Postnatal differentiation of basket cells from slow to fast signaling devices. J Neurosci 28, 12956–12968
Sohal, V.S., Zhang, F., Yizhar, O., and Deisseroth, K. (2009). Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459, 698–702
Alexander, G.E., and Goldman, P.S. (1978). Functional development of the dorsolateral prefrontal cortex: an analysis utilizing reversible cryogenic depression. Brain Res 143, 233–249
Rao, S.G., Williams, G.V., and Goldman-Rakic, P.S. (2000). Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20, 485–494
Wilson, F.A., O’Scalaidhe, S.P., and Goldman-Rakic, P.S. (1994). Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. Proc Natl Acad Sci USA 91, 4009–4013
Goldman-Rakic, P.S. (1999). The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol Psychiatry 46, 650–661
Kawaguchi, Y. (2001). Distinct firing patterns of neuronal subtypes in cortical synchronized activities. J Neurosci 21, 7261–7272
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., and Wu, C. (2004). Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5, 793–807
Gonzalez-Burgos, G., and Lewis, D.A. (2008). GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 34, 944–961
Uhlhaas, P.J., Haenschel, C., Nikolic, D., and Singer, W. (2008). The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 34, 927–943
Jentsch, J.D., and Roth, R.H. (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201–225
Le Pen, G., Grottick, A.J., Higgins, G.A., and Moreau, J.L. (2003). Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia. Neuropsychopharmacology 28, 1799–1809
Stefani, M.R., and Moghaddam, B. (2002). Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res 134, 267–274
Krystal, J.H., Perry, E.B., Jr., Gueorguieva, R., Belger, A., Madonick, S.H., Abi-Dargham, A., Cooper, T.B., Macdougall, L., Abi-Saab, W., and D’Souza, D.C. (2005). Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62, 985–994
Stoet, G., and Snyder, L.H. (2006). Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control. Neuropsychopharmacology 31, 1675–1681
Behrens, M.M., Ali, S.S., Dao, D.N., Lucero, J., Shekhtman, G., Quick, K.L., and Dugan, L.L. (2007). Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318, 1645–1647
Cochran, S.M., Kennedy, M., McKerchar, C.E., Steward, L.J., Pratt, J.A., and Morris, B.J. (2003). Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28, 265–275
Morrow, B.A., Elsworth, J.D., and Roth, R.H. (2007). Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex. Psychopharmacology (Berl) 192, 283–290
Zhang, Y., Behrens, M.M., and Lisman, J.E. (2008). Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol 100, 959–965
Jonas, P., Bischofberger, J., Fricker, D., and Miles, R. (2004). Interneuron Diversity series: fast in, fast out – temporal and spatial signal processing in hippocampal interneurons. Trends Neurosci 27, 30–40
Bergles, D.E., Doze, V.A., Madison, D.V., and Smith, S.J. (1996). Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J Neurosci 16, 572–585
Gorelova, N., Seamans, J.K., and Yang, C.R. (2002). Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. J Neurophysiol 88, 3150–3166
Jones, S., and Yakel, J.L. (1997). Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504 (Pt 3), 603–610
Gulyas, A.I., Megias, M., Emri, Z., and Freund, T.F. (1999). Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci 19, 10082–10097
Hull, C., and Scanziani, M. (2007). It’s about time for thalamocortical circuits. Nat Neurosci 10, 400–402
Daw, M.I., Ashby, M.C., and Isaac, J.T. (2007). Coordinated developmental recruitment of latent fast spiking interneurons in layer IV barrel cortex. Nat Neurosci 10, 453–461
de Lecea, L., del Rio, J.A., and Soriano, E. (1995). Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat. Brain Res Mol Brain Res 32, 1–13
Chattopadhyaya, B., Di Cristo, G., Wu, C.Z., Knott, G., Kuhlman, S., Fu, Y., Palmiter, R.D., and Huang, Z.J. (2007). GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 54, 889–903
Di Cristo, G., Wu, C., Chattopadhyaya, B., Ango, F., Knott, G., Welker, E., Svoboda, K., and Huang, Z.J. (2004). Subcellular domain-restricted GABAergic innervation in primary visual cortex in the absence of sensory and thalamic inputs. Nat Neurosci 7, 1184–1186
Kinney, J.W., Davis, C.N., Tabarean, I., Conti, B., Bartfai, T., and Behrens, M.M. (2006). A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 26, 1604–1615
Dichter, M.A. (1978). Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation. Brain Res 149, 279–293
Dichter, M.A. (1980). Physiological identification of GABA as the inhibitory transmitter for mammalian cortical neurons in cell culture. Brain Res 190, 111–121
Kato-Negishi, M., Muramoto, K., Kawahara, M., Kuroda, Y., and Ichikawa, M. (2004). Developmental changes of GABAergic synapses formed between primary cultured cortical neurons. Brain Res Dev Brain Res 152, 99–108
Lesuisse, C., and Martin, L.J. (2002). Long-term culture of mouse cortical neurons as a model for neuronal development, aging, and death. J Neurobiol 51, 9–23
Zona, C., Palma, E., Brancati, A., and Avoli, M. (1994). Age-dependent appearance of synaptic currents in rat neocortical neurons in culture. Synapse 18, 1–6
Jovanovic, J.N., Thomas, P., Kittler, J.T., Smart, T.G., and Moss, S.J. (2004). Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability. J Neurosci 24, 522–530
Muir, J.K., Lobner, D., Monyer, H., and Choi, D.W. (1996). GABAA receptor activation attenuates excitotoxicity but exacerbates oxygen-glucose deprivation-induced neuronal injury in vitro. J Cereb Blood Flow Metab 16, 1211–1218
Behrens, M.M., Strasser, U., Koh, J.Y., Gwag, B.J., and Choi, D.W. (1999). Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase. Neuroscience 94, 917–927
Behrens, M.M., Strasser, U., Lobner, D., and Dugan, L.L. (1999). Neurotrophin-mediated potentiation of neuronal injury. Microsc Res Tech 45, 276–284
Dugan, L.L., Bruno, V.G., Amagasu, S.M., and Giffard, R.G. (1995). Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity. J Neurosci 15, 4545–4555
Heidinger, V., Manzerra, P., Wang, X.Q., Strasser, U., Yu, S.P., Choi, D.W., and Behrens, M.M. (2002). Metabotropic glutamate receptor 1-induced upregulation of NMDA receptor current: mediation through the Pyk2/Src-family kinase pathway in cortical neurons. J Neurosci 22, 5452–5461
Kim, M.J., Dunah, A.W., Wang, Y.T., and Sheng, M. (2005). Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron 46, 745–760
Yu, S.P., Canzoniero, L.M., and Choi, D.W. (2001). Ion homeostasis and apoptosis. Curr Opin Cell Biol 13, 405–411
Behrens, M.M., Ali, S.S., and Dugan, L.L. (2008). Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28, 13957–13966
Cauli, B., Audinat, E., Lambolez, B., Angulo, M.C., Ropert, N., Tsuzuki, K., Hestrin, S., and Rossier, J. (1997). Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci 17, 3894–3906
Xi, D., Keeler, B., Zhang, W., Houle, J.D., and Gao, W.J. (2009). NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique. J Neurosci Methods 176, 172–181
Xia, S., Cai, Z.Y., Thi, L.L., Kim-Han, J.S., Dugan, L.L., Covey, D.F., and Rothman, S.M. (2002). The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analog. Neurobiol Dis 9, 282–293
Fejgin, K., Palsson, E., Wass, C., Svensson, L., and Klamer, D. (2008). Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine. Neuropsychopharmacology 33, 1874–1883
Zuo, D.Y., Wu, Y.L., Yao, W.X., Cao, Y., Wu, C.F., and Tanaka, M. (2007). Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 86, 1–7
Papadia, S., Soriano, F.X., Leveille, F., Martel, M.A., Dakin, K.A., Hansen, H.H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V., McKenzie, G., Craigon, M., Corriveau, R., Ghazal, P., Horsburgh, K., Yankner, B.A., Wyllie, D.J., Ikonomidou, C., and Hardingham, G.E. (2008). Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci 11, 476–487
Muller, N., Riedel, M., Gruber, R., Ackenheil, M., and Schwarz, M.J. (2000). The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci 917, 456–467
Ganguli, R., Yang, Z., Shurin, G., Chengappa, K.N., Brar, J.S., Gubbi, A.V., and Rabin, B.S. (1994). Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51, 1–10
Naudin, J., Mege, J.L., Azorin, J.M., and Dassa, D. (1996). Elevated circulating levels of IL-6 in schizophrenia. Schizophr Res 20, 269–273
Nunes, S.O., Borelli, S.D., Matsuo, T., Watanabe, M.A., and Itano, E.N. (2005). The association of the HLA in patients with schizophrenia, schizoaffective disorder, and in their biological relatives. Schizophr Res 76, 195–198
Kudoh, A., Takase, H., Takahira, Y., Katagai, H., and Takazawa, T. (2003). Postoperative confusion in schizophrenic patients is affected by interleukin-6. J Clin Anesth 15, 455–462
Lin, A., Kenis, G., Bignotti, S., Tura, G.J., De Jong, R., Bosmans, E., Pioli, R., Altamura, C., Scharpe, S., and Maes, M. (1998). The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res 32, 9–15
Zhang, X.Y., Zhou, D.F., Zhang, P.Y., Wu, G.Y., Cao, L.Y., and Shen, Y.C. (2002). Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 57, 247–258
Goslin, K., Asmussen, H., and Banker, G. (1998). Rat hippocampal neurons in low-density culture. In Goslin, K., and Banker, G. (ed.), Culturing nerve cells, 2nd edition (London: The MIT Press), pp. 339–370
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Behrens, M.M. (2011). Studying Schizophrenia in a Dish: Use of Primary Neuronal Cultures to Study the Long-Term Effects of NMDA Receptor Antagonists on Parvalbumin-Positive Fast-Spiking Interneurons. In: O'Donnell, P. (eds) Animal Models of Schizophrenia and Related Disorders. Neuromethods, vol 59. Humana Press. https://doi.org/10.1007/978-1-61779-157-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-61779-157-4_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-156-7
Online ISBN: 978-1-61779-157-4
eBook Packages: Springer Protocols